Devyser Diagnostics Logo

Devyser Diagnostics

Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.

DVYSR | ST

Overview

Corporate Details

ISIN(s):
SE0016588867 (+1 more)
LEI:
549300RV4Z2K3360CK30
Country:
Sweden
Address:
Instrumentvägen 19, 126 53 Hägersten
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Devyser Diagnostics is a company specializing in the development, manufacture, and sale of advanced diagnostic kits for genetic DNA testing. Serving clinical laboratories, its product portfolio addresses critical areas such as reproductive health, oncology for guiding targeted cancer therapies, and post-transplant monitoring. Devyser's core mission is to simplify and streamline complex laboratory workflows by providing fast, accurate, and user-friendly solutions. The company's end-to-end tests are designed to significantly reduce sample-to-result times and manual handling, aiming to enhance laboratory efficiency, enable quicker patient diagnoses, and advance the accessibility of personalized medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Devyser Diagnostics filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Devyser Diagnostics via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-14 Mia Arnhult Other Buy 7,000 745,290.00 SEK

Peer Companies

Company Country Ticker View
Double Bond Pharmaceutical International AB Logo
Redeveloping drugs with proprietary delivery tech for oncology & infectious diseases.
Sweden DBP B
Develops & commercializes PET/CT tracers for diagnosing cancer & neurological disorders.
South Korea 176750
Dx & Vx Co., Ltd. Logo
Develops innovative diagnostics & vaccines and provides comprehensive life science contract services.
South Korea 180400
Manufactures vet pharma for livestock/aquaculture & distributes premium pet food.
South Korea 044960
ECO ANIMAL HEALTH GROUP PLC Logo
Develops pharmaceuticals for respiratory & enteric diseases in global swine and poultry markets.
United Kingdom EAH
Ectin Research AB Logo
Clinical-stage biotech developing novel cancer treatments, focusing on metastatic bladder cancer.
Sweden ECTIN B
Eevia Health Plc Logo
Manufactures validated polyphenol extracts from Arctic plants for the supplement & food industries.
Finland EEVIA
Egetis Therapeutics Logo
Develops and commercializes drugs for serious rare diseases with unmet medical needs.
Sweden EGTX
EIKEN CHEMICAL CO.,LTD. Logo
Manufacturer of clinical diagnostics, specializing in FIT systems for cancer and microbiological tests.
Japan 4549
Eisai Co., Ltd. Logo
A global, research-based pharmaceutical firm that develops and markets prescription and OTC drugs.
Japan 4523

Talk to a Data Expert

Have a question? We'll get back to you promptly.